1.Discussion on Bufei Decoction in the treatment of stable COPD based on theory of "Latent Toxin Entering Lung"
Wen ZHANG ; Qiong ZHANG ; Yi HE ; Muyang JIN ; Xinyu ZHANG ; Ruiling ZHOU
International Journal of Traditional Chinese Medicine 2023;45(11):1345-1349
Chronic obstructive pulmonary disease (COPD) is characterized by excess in nature and deficiency in superficiality. For COPD patients, the deficiency of lung and kidney is the basis for production of the latent toxin, and repeated exogenous infection is the main factor for the latent toxin to enter the lung. The key pathogenesis of stable COPD is the entry of latent toxin into the lung and the injury of lung and collaterals. Therefore, tonifying lung and kidney, removing toxins and dredging collaterals are the core treatment methods for COPD in stable period. Bufei Decoction is with good efficacy in the treatment of COPD in stable period, which can not only tonify lung and kidney to consolidate, but also dredging collaterals to remove toxins. Based on the pathogenesis of "latent toxin entering lung", the relevant mechanisms of Bufei Decoction in treating stable COPD were further understood and explored, in order to benefit clinical practice.
2.Research Progress of Magnetic Resonance Imaging-based Radiomics in Prostate Cancer.
Jia-Hui ZHANG ; Li-Li XU ; Gu-Muyang ZHANG ; Hao SUN ; Zheng-Yu JIN
Acta Academiae Medicinae Sinicae 2022;44(1):123-129
Radiomics can extract high-throughput and quantitative image features from medical images and mine the information related to the pathophysiology of tumors,which can help clinical decision-making and improve the diagnostic and predictive performance.Radiomics has been widely used in the study of prostate cancer (PCa),demonstrating application values in the diagnosis and differential diagnosis,pathology classification,invasion assessment,efficacy prediction,and prognosis analysis of PCa.Here we reviewed the recent research progress of magnetic resonance imaging-based radiomics in PCa.
Humans
;
Magnetic Resonance Imaging/methods*
;
Male
;
Prognosis
;
Prostatic Neoplasms/pathology*